Our partner is a U.S.-based pharmaceutical manufacturer specializing in sterile injectables and radiopharmaceuticals used in cancer diagnostics and treatment. They offer contract manufacturing and development services, with a focus on high-quality, non-cytotoxic injectable products, and have expanded their capabilities through global partnership.

This critical hire provided expert scientific insight to support drug development strategies, offering guidance on study design, data interpretation, and regulatory submissions. They collaborated with cross-functional teams to ensure scientific integrity and alignment with project goals, leveraging their deep subject matter expertise to drive informed decision-making across clinical and regulatory initiatives.